AI Generated Image
Is the US seeing a turning point in obesity rates?
DW.com • • health
Key Points:
- Recent studies and surveys suggest that obesity rates in the United States may have declined slightly in 2023, marking the first such decrease in over a decade.
- The surge in prescriptions of GLP-1 agonist drugs like Ozempic, Wegovy, and Zepbound, which promote weight loss by mimicking intestinal hormones, is considered a significant factor contributing to this decline.
- Experts caution that while these medications have shown individual effectiveness, it is too soon to confirm a long-term population-level impact or a permanent reversal of obesity trends.
- Other factors such as lifestyle changes following the COVID-19 pandemic and increased awareness about weight management may also be influencing the recent decline in obesity rates.
- Despite hopeful signs, obesity remains a major public health crisis in the US, with concerns about drug accessibility and the need for continued attention, funding, and alternative solutions.
